tiprankstipranks
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
PremiumPress ReleasesXOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
2M ago
Xoma reports 2023 EPS ($4.04) vs. ($1.98) last year
PremiumThe Fly
Xoma reports 2023 EPS ($4.04) vs. ($1.98) last year
2M ago
Is XOMA a Buy, Before Earnings?
PremiumPre-Earnings
Is XOMA a Buy, Before Earnings?
2M ago
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
PremiumPress ReleasesXOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
3M ago
Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR
PremiumThe Fly
Xoma to acquire Kinnate for between $2.3352-$2.5879 per share plus CVR
3M ago
Xoma to acquire Kinnate Biopharma for between $2.3352-$2.5879 per share plus CVR
PremiumThe Fly
Xoma to acquire Kinnate Biopharma for between $2.3352-$2.5879 per share plus CVR
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100